Changes to Tricare claims process cause trouble for local mental health providers, military families
On Jan.1, a company named for the Tricare East Region.
However, a spokesperson for Humana Military, the regional contractor for the East Region, told NBC News that a 'small percentage' of provider records in the claims administration system had outdated or incorrect data that prevented claims from being processed in January.
As a result of this, some local providers told 10 On Your Side they haven't been paid by Tricare since the beginning of the year.
About 25% of clients that Lighthouse Counseling in Virginia Beach serve use Tricare. The practice said some of their counselors aren't getting paid for the service they provide to those clients.
Elizabeth Hunter, a licensed professional counselor at Lighthouse Counseling, said she has not been paid by Tricare since January. She estimates she is owed around $6,000.
'When Tricare switched claims processing companies, that data migration didn't happen well and data was lost, and my credentialing was lost in that process,' Hunter said.
Hunter explained that because she is a licensed professional counselor, her Tricare patients now have to get a referral through their primary care manager to continue to see her or it won't be covered.
'My last client of the day told me [that] 'to get a physician's referral will take me three months. I cannot pay out of pocket, and I don't know what to do,'' Hunter said.
Months after the claims change, Meichell Worthing, Lighthouse Counseling owner, said the situation is continuing to impact her business.
'Tricare represents roughly $25,000 a month for our practice,' Worthing said. 'And so, we're at three months in, that's about $75,000 that we are out of on some level. They did give us a prepayment in January for some money to help the transition, but then haven't really helped since then, and we're still in the scenario where many of our counselors have not been paid for the services they've already provided.'
Meanwhile, Lighthouse Counseling clients that use Tricare such as Alex Arnold are trying to figure out what to do next.
'I don't have a [primary care manager] to monitor my health, because nobody's taking me in the time that the Navy has me here, which is only eight months,' Arnold said. 'I don't have many necessities healthcare-wise, [but] I would almost rather go with a broken arm for eight months than [going] without counseling for eight months.'
Going forward, Lighthouse Counseling offered its Tricare clients a new system where they will prepay for their services and the practice will reimburse them once Tricare pays them.
'Our servicemen and women and their families deserve better,' Hunter said. 'They should not be having to go through this. They struggle enough, they have sacrificed enough and they should not have to sacrifice their mental health care because of some glitch in the system. Fix it sooner [rather] than later. Stop trying to deny it, stop trying to give misinformation. Figure out what the left hand is doing and what the right hand is doing and make it right.'
10 On Your Side has reached out to Humana Military for comment on this story and has not received a response.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 days ago
- Yahoo
Adia Nutrition Inc. Supports Heroes and Their Families with TRICARE In-Network Application, Advancing Regenerative Care Through Adia Med
Winter Park, Florida--(Newsfile Corp. - July 23, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized wellness solutions, is thrilled to announce that its medical subsidiary, Adia Med, has officially filed to become an in-network provider with TRICARE, the healthcare program serving approximately 9.5 million active-duty service members, retirees, National Guard and Reserve members, and their families worldwide. This step, paired with Adia Med's anticipated approval as a United Healthcare provider by August 1, 2025, positions the company to transform healthcare access for millions. Adia Med expects to secure TRICARE in-network provider status by August 31, 2025, tapping into a program that paid out $50.6 billion for medical treatments in FY2019 to support its beneficiaries. Evaluation of the TRICARE Program: Fiscal Year 2019 Report to Congress. To view an enhanced version of this graphic, please visit: This strategic filing positions Adia Med to serve TRICARE's extensive network of beneficiaries, including military personnel and their families, by offering innovative regenerative treatments such as Umbilical Cord Blood Stem Cell (UCB-SC) therapies, Autologous Hematopoietic Stem Cell Transplantation (AHSCT), and Therapeutic Plasma Exchange (TPE). These therapies, provided at Adia Med's Winter Park clinic and planned satellite locations, target conditions like Multiple Sclerosis, joint pain, torn tendons, and other orthopedic and wellness needs, aligning with Adia Nutrition's mission to revolutionize healthcare accessibility. "We're fired up to support the 9.5 million TRICARE beneficiaries, including our nation's military heroes and their families, by bringing our regenerative therapies into their reach," said Larry Powalisz, CEO of Adia Nutrition Inc. "With TRICARE's massive $50.6 billion investment in medical care, our filing to join their network, alongside our imminent United Healthcare approval, will make advanced treatments more accessible and affordable, driving transformative health outcomes and fueling Adia Med's growth." The TRICARE filing complements Adia Med's recent progress with United Healthcare, where the company has already begun submitting its first patient insurance claims, signaling near-final integration. By securing in-network status with both TRICARE and United Healthcare, Adia Med will join an elite group of providers meeting rigorous standards for clinical excellence, compliance, and patient care. These partnerships will enable insurance reimbursement for Adia Med, enhancing affordability and accessibility for patients seeking innovative treatments. For questions, inquiries or further information, please contact Larry Powalisz at ceo@ or 321-788-0850. About ADIA Nutrition Inc.:Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments. Website: Website: (X): @ADIA_Nutrition Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise. To view the source version of this press release, please visit Sign in to access your portfolio
Yahoo
10-07-2025
- Yahoo
CVS Omnicare ordered to pay $949 million in government fraud case
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. A federal judge has ordered CVS to pay $948.8 million in penalties and damages in a whistleblower case alleging that the company's Omnicare division illegally charged the U.S. government for prescription drugs. Manhattan Judge Colleen McMahon imposed a $542 million penalty for what she called 'very big fraud' in her Monday order, and awarded $406.8 million in damages — three times the $135.6 million that a jury awarded in the spring, as required under the False Claims Act. Omnicare filed more than 3.3 million false claims between 2010 and 2018, according to court documents. CVS, which acquired the pharmacy benefits manager in 2015, denied the allegations and said it planned to appeal McMahon's decision. A former Omnicare pharmacist filed the lawsuit in 2015 accusing the PBM of improperly billing Medicare, Medicaid and the military's Tricare program for over $135 million in drugs that weren't actually covered by the programs. Omnicare — the largest long-term care pharmacy services provider in the U.S. — fraudulently dispensed drugs to elderly and disabled people in long-term care and assisted living facilities without valid prescriptions, according to the complaint. The Department of Justice joined the suit in 2019, and a jury ruled in favor of the government last spring. The False Claims Act allows whistleblowers to bring complaints on the government's behalf and share in potential damages. The law is a key weapon in the government's arsenal for combating fraud, and the driving force behind a major share of healthcare recoveries. The law requires tripling of damages, a stipulation that inflated CVS' penalty. The company argued that the $948.8 million award violates the Constitution's prohibition against excessive fines, but McMahon did not agree. 'Admittedly [the fine] is a very big number. But this was a very big fraud on the Government, one that lasted over almost a decade, and one that Omnicare was aware of but avoided taking steps to correct,' the judge wrote. And CVS is getting off relatively easy, McMahon noted. According to her order, following the letter of the FCA, which outlines a minimum penalty of $5,000 for every false claim, would result in an 'astronomical' minimum penalty of $26.9 billion on top of the damages. Still, CVS plans to appeal the judgment. 'This lawsuit centered on a highly technical prescription dispensing record keeping issue that was allowed by law in many states. The dispensing practices referenced were limited to Omnicare, ended in 2018, were used by many others in the industry at the time, and were accepted by CMS,' a spokesperson for the company said. 'There was no claim in this case that any patient paid for a medication they shouldn't have or that any patient was harmed. The decision on penalties is unconstitutional, especially given the fact that there is no evidence that a single patient suffered harm,' they added. If the healthcare juggernaut's appeal fails, the penalty is small hit in comparison to its annual revenue, which reached $372.8 billion in 2024. Still, it would mean a financial speedbump for CVS, which is struggling to adjust to reimbursement pressures in its legacy retail pharmacy business and higher medical costs for members in its Aetna health plans. Recommended Reading DOJ charges more than 300 in $14.6B healthcare fraud bust
Boston Globe
10-07-2025
- Boston Globe
CVS ordered to pay $949m over invalid prescriptions in federal lawsuit
Omnicare specializes in providing services to assisted-living communities, nursing homes, and other long-term care settings. The acquisition was CVS's attempt to broaden its presence in the specialty pharmacy business as it sought to capitalize on an aging population. Omnicare is now the largest long-term care pharmacy services provider in the country. Get Rhode Map A weekday briefing from veteran Rhode Island reporters, focused on the things that matter most in the Ocean State. Enter Email Sign Up Uri Bassan, a former Omnicare pharmacist in Albuquerque, N.M., first filed the suit in 2015. The US Department of Justice joined the suit in 2019. Both parties accused Omnicare of improperly billing Medicare, Medicaid, and Tricare prescriptions for patients in assisted-living communities, group homes, and other long-term care facilities without valid prescriptions. Advertisement CVS plans to appeal. 'This lawsuit centered on a highly technical prescription dispensing record keeping issue that was allowed by law in many states,' said Ethan Slavin, a spokesman for CVS, in a statement to the Globe on Thursday. 'The dispensing practices referenced were limited to Omnicare, ended in 2018, were used by many others in the industry at the time.' Slavin said the practices were accepted by the federal Centers for Medicare & Medicaid Services. Advertisement Slavin said there was no claim in the case that 'any patient paid for a medication they shouldn't have or that any patient was harmed.' A jury 'False claims in the healthcare industry cost every American,' said US Attorney Jay Clayton The False Claims Act allows whistleblowers to bring complaints on the federal government's behalf. The law is key for the government to combat fraud. The law requires tripling of damages, which inflated CVS' penalty. But the company argues the award violates the Constitution's barring of excessive fines. 'The decision on penalties is unconstitutional, especially given the fact that there is no evidence that a single patient suffered harm,' said Slavin. 'We plan to appeal once the judgment is entered.' In 2024, CVS Health reported McMahon wrote in her order that while the fine 'is a very big number,' this 'was a very big fraud on the government, one that lasted over almost a decade, and that Omnicare was aware of but avoided taking steps to correct.' Alexa Gagosz can be reached at
